To our customers (both future and current): I have always believed that in order to change something, you have to be willing to have a tough conversation. We’ve done that as a company since we launched in 2017 because we know progress requires honesty before it provides hope. Our latest ad, which will air at the big game next weekend, is meant to provoke a long overdue tough conversation. It’s meant to recognize that you deserve better. No one should be satisfied with a system that requires you to get sick before you’re allowed to get healthy. This isn’t about advertising any one specific treatment. This is about speaking directly to you about the future we know all Americans deserve, whether you live in a rural community, a big city, or somewhere in between. This is about being a loud, unapologetic advocate for what we know care can and should look like for everyone in this country: affordable, proactive, and built to empower the individual. In order for health outcomes in the US to really improve, we have to stop gatekeeping innovative, proactive tools and care. Real, lasting health requires having access to transparent information *and* innovation that can help prevent - not just treat - disease. Meaningful change requires two things: the conviction to reimagine a better way and the stamina to make it a reality. My promise to all of you is that I’ll make sure Hims & Hers always has both. Let’s close the health gap.

Today we announce a strategic investment in $GRAL — the most advanced Multi-Cancer Early Detection (MCED) test on the market. When I was 12, my father was diagnosed with stage 4 colon cancer. He was 38 at the time, about the same age as I am today. Since hearing about early detection cancer tests nearly 5 years ago, I’ve been obsessed with finding ways to get more people I love access. I started with my family a few years back, and most recently my friends. With today’s announcement, I’m now focused on all of you. The ability to detect cancer in its early stages was a dream when I was a kid. It was what I wanted more than anything after my dad was diagnosed. What $GRAL can do today is nothing short of magic. It is flipping cancer diagnosis on its head. Imagine the ability to catch it early. No more surprises, no more “if onlys.” Just a simple, annual blood test that’s as easy as going to the dentist. For many, it could be life-changing, helping you or a family member find out early, when something can hopefully be done. Today’s strategic investment is the first of many like it, in our pursuit to curate the absolute best in advanced healthcare. This deal, though, is special to me, and I couldn’t be more excited to one day bring it to you and the people you love. grail.com/press-releases/gra… Note on forward-looking statements: news.hims.com/disclaimers/ca…

Hers continues to be one of the most powerful growth engines in our business, serving more than 500,000 women today and on track to deliver over $1B in revenue next year. This launch marks another step toward expanding our leadership in women’s health and meeting demand for care that’s built around women’s real needs.